Persistent URL of this record https://hdl.handle.net/1887/113016
In Collections
This item can be found in the following collections:
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF TWO DIFFERENT DOSES OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) FOR THE TREATMENT OF CIDP: IGG DEPENDENCY AND RESTABILIZATION PHASE
- All authors
- Schaik, I.N. van; Bril, V.; Geloven, N. van; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Durn, B.; Lawo, J.P.; Mielke, O.; Cornblath, D.R.; Merkies, I.S.J.; PATH Study Grp
- Date
- 2016-09-30
- Volume
- 21
- Issue
- 3
- Pages
- 221 - 221